| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.088 | 0.5 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |